Wockhardt

1,295.05
+61.65
(5.00%)
Market Cap (₹ Cr.)
₹20,000
52 Week High
1,334.65
Book Value
₹
52 Week Low
323.50
PE Ratio
PB Ratio
4.55
PE for Sector
39.28
PB for Sector
3.95
ROE
%
ROCE
-2.37 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
3.89 %
Net Income Growth
23.99 %
Cash Flow Change
43.14 %
ROE
23.99 %
ROCE
64.22 %
EBITDA Margin (Avg.)
-47.34 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
499
522
573
649
527
631
789
568
558
462
601
547
924
548
643
515
476
249
329
269
195
1,658
310
263
270
282
314
312
496
290
287
300
320
257
266
293
379
379
381
Expenses
496
511
564
510
499
559
579
525
491
517
536
517
585
499
562
527
476
296
244
261
223
901
307
261
286
262
301
294
288
236
297
256
506
270
270
263
401
272
321
EBITDA
3
11
10
139
28
72
211
43
68
-55
65
30
339
49
81
-12
0
-47
85
9
-28
757
3
2
-16
20
13
18
208
54
-10
44
-186
-13
-4
30
-22
107
60
Operating Profit %
-1 %
0 %
1 %
19 %
2 %
9 %
3 %
4 %
9 %
-18 %
9 %
3 %
36 %
7 %
11 %
-4 %
-2 %
-38 %
20 %
-25 %
-37 %
-407 %
-4 %
-3 %
-9 %
6 %
3 %
5 %
39 %
2 %
-15 %
9 %
-74 %
-8 %
-4 %
9 %
-13 %
23 %
13 %
Depreciation
25
25
25
26
24
26
27
28
25
27
26
27
27
28
29
30
36
44
41
44
45
46
43
43
52
43
43
43
43
47
47
47
45
44
44
43
45
43
43
Interest
6
17
25
28
39
44
42
42
41
43
44
41
42
38
43
42
47
56
54
52
58
59
47
49
45
55
60
79
78
61
58
52
58
58
59
61
59
58
53
Profit Before Tax
-28
-31
-40
86
-35
2
142
-26
2
-125
-4
-38
270
-17
9
-84
-83
-147
-10
-87
-131
652
-87
-90
-113
-78
-90
-104
87
-54
-115
-55
-289
-115
-107
-74
-126
6
-36
Tax
-14
0
5
2
-35
2
33
0
0
0
0
0
22
0
0
0
0
-14
-12
4
-11
-70
-16
-22
-28
0
0
0
5
0
0
0
0
0
0
0
0
0
0
Net Profit
-14
-31
-45
84
1
16
146
-20
-6
-102
25
-28
172
-15
5
-38
-34
-83
0
-70
-79
766
-57
-69
-47
-49
-64
-67
40
-37
-75
-55
-299
-115
-107
-74
-126
6
-36
EPS in ₹
-1.28
2.86
-4.09
7.62
0.07
1.48
13.22
-1.80
-0.54
-9.19
2.29
-2.49
15.59
-1.37
0.46
-3.46
-3.03
-7.49
0.01
-6.31
-7.08
69.21
-5.18
-6.20
-4.25
-4.40
-5.30
-6.06
3.32
-2.62
-5.17
-3.81
-20.80
-8.01
-7.39
-5.14
-8.71
0.39
-2.34

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
4,149
4,584
4,569
4,386
4,538
4,760
4,895
5,798
4,732
4,868
Fixed Assets
1,006
1,402
1,465
1,423
1,614
2,044
1,684
1,828
1,625
1,449
Current Assets
1,573
2,021
1,797
1,667
1,830
1,607
1,839
2,388
1,475
1,779
Capital Work in Progress
792
664
665
653
381
305
716
825
823
833
Investments
0
297
297
297
297
297
297
297
297
297
Other Assets
2,351
2,221
2,142
2,013
2,245
2,113
2,198
2,848
1,987
2,289
Total Liabilities
4,149
4,584
4,569
4,386
4,538
4,760
4,895
5,798
4,732
4,868
Current Liabilities
2,046
1,293
1,594
1,789
1,828
2,305
2,603
3,049
2,626
1,888
Non Current Liabilities
733
2,123
1,755
1,302
1,484
1,460
686
537
353
1,184
Total Equity
1,370
1,168
1,219
1,295
1,227
995
1,606
2,212
1,753
1,796
Reserve & Surplus
1,017
1,113
1,164
1,239
1,171
939
1,551
2,140
1,681
1,719
Share Capital
354
55
55
55
55
55
55
72
72
77

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
575
-614
1
46
109
-69
-29
93
-168
459
Investing Activities
203
-1,015
369
451
120
-16
1,014
-244
-3
-75
Operating Activities
-53
-363
-235
119
58
222
-563
-93
71
188
Financing Activities
425
764
-133
-524
-69
-274
-480
430
-236
346

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Nov 2024
Promoter
72.12 %
69.68 %
68.04 %
67.13 %
67.13 %
65.75 %
63.83 %
60.36 %
59.31 %
58.40 %
55.14 %
54.93 %
51.60 %
51.99 %
51.99 %
49.09 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.02 %
0.00 %
5.49 %
5.93 %
6.70 %
6.62 %
DIIs
0.02 %
0.02 %
0.02 %
0.03 %
0.03 %
0.03 %
0.03 %
0.23 %
0.22 %
0.19 %
0.22 %
0.10 %
4.83 %
4.45 %
5.09 %
9.88 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.02 %
0.02 %
Public / Retail
21.41 %
23.02 %
25.24 %
25.99 %
24.56 %
25.97 %
27.42 %
30.26 %
31.45 %
32.19 %
32.89 %
32.94 %
29.94 %
30.18 %
29.02 %
27.45 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,798.90 4,31,352.44 38.48 49,887.17 12.06 9,648 27.35 45.44
1,503.30 1,20,032.91 26.00 26,520.66 14.17 4,155 12.95 44.98
2,610.10 1,02,230.95 48.33 10,615.63 19.57 1,942 28.89 50.46
1,209.30 1,01,285.96 18.97 28,905.40 12.36 5,578 -9.47 35.84
964.35 95,461.42 22.32 19,831.50 13.82 3,831 14.57 41.12
2,107.15 94,430.07 35.96 20,141.50 19.94 1,936 73.52 48.62
1,241.75 71,698.38 19.66 29,559.25 17.55 3,169 8.65 26.17
5,478.30 66,621.02 30.64 12,978.42 9.84 1,811 14.16 35.52
1,490.40 41,765.26 - 12,653.09 6.58 -1,831 675.84 32.40
1,607.15 40,352.92 60.09 7,829.81 22.92 529 80.05 57.57

Corporate Action

Technical Indicators

RSI(14)
Neutral
64.16
ATR(14)
Less Volatile
61.30
STOCH(9,6)
Neutral
42.01
STOCH RSI(14)
Neutral
39.47
MACD(12,26)
Bearish
-1.98
ADX(14)
Weak Trend
18.17
UO(9)
Bearish
57.19
ROC(12)
Uptrend And Accelerating
1.88
WillR(14)
Overbought
-19.36